IndraLab

Statements

Sirolimus activates KCNA3. 1 / 1

| 1

reach

"To examine the role of these pathways in tumor cell growth and metastatic ability, we measured cell growth in OIP5 expressing HLK3 cells treated with the mTORC1 inhibitor rapamycin (RPM, 100 nM) or the beta-catenin inhibitor cardamonin (CDM, 10 muM)."

28184024

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Sirolimus activates KCNA3. 1 / 1

INDRA sources:

Databases

Reading